Adjuvant endocrine therapy for premenopausal women with early breast cancer

被引:0
|
作者
Ting Bao
Nancy E Davidson
机构
[1] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center
来源
关键词
Tamoxifen; Endocrine Therapy; Premenopausal Woman; GnRH Agonist; Exemestane;
D O I
暂无
中图分类号
学科分类号
摘要
Adjuvant endocrine therapy is a pivotal component of treatment for premenopausal women with early-stage hormone receptor-positive breast cancer. Currently, the standard endocrine therapy for premenopausal women is tamoxifen; a role for ovarian suppression or ablation has also been identified. Uncertainty remains about the optimal use of endocrine therapy in this setting. The role of ovarian suppression with tamoxifen or aromatase inhibitor, the optimal duration of adjuvant endocrine therapy and the utility of biomarkers and pharmacogenetic studies to select therapy are questions worthy of further investigation.
引用
收藏
相关论文
共 50 条
  • [21] Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
    Francis, P. A.
    Pagani, O.
    Fleming, G. F.
    Walley, B. A.
    Colleoni, M.
    Lang, I.
    Gomez, H. L.
    Tondini, C.
    Ciruelos, E.
    Burstein, H. J.
    Bonnefoi, H. R.
    Bellet, M.
    Martino, S.
    Geyer, C. E., Jr.
    Goetz, M. P.
    Stearns, V.
    Pinotti, G.
    Puglisi, F.
    Spazzapan, S.
    Climent, M. A.
    Pavesi, L.
    Ruhstaller, T.
    Davidson, N. E.
    Coleman, R.
    Debled, M.
    Buchholz, S.
    Ingle, J. N.
    Winer, E. P.
    Maibach, R.
    Rabaglio-Poretti, M.
    Ruepp, B.
    Di Leo, A.
    Coates, A. S.
    Gelber, R. D.
    Goldhirsch, A.
    Regan, M. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02): : 122 - 137
  • [22] LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
    Sharma, Rohini
    Hamilton, Anne
    Beith, Jane
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [23] LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
    Goel, Shom
    Sharma, Rohini
    Hamilton, Anne
    Beith, Jane
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [24] Adjuvant endocrine therapy for perimenopausal women with early breast cancer
    Ortmann, Olaf
    Cufer, Tanja
    Dixon, J. Michael
    Maass, Nicolai
    Marchetti, Paolo
    Pagani, Olivia
    Pronzato, Paolo
    Semiglazov, Vladimir
    Spano, Jean-Philippe
    Vrdoljak, Eduard
    Wildiers, Hans
    BREAST, 2009, 18 (01): : 2 - 7
  • [25] Adjuvant endocrine therapy for postmenopausal women with early breast cancer
    Ingle, JN
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1031S - 1036S
  • [26] Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy
    Sverrisdóttir, A
    Fornander, T
    Jacobsson, H
    von Schoultz, E
    Rutqvist, LE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3694 - 3699
  • [27] Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
    Pan, Kathy
    Bosserman, Linda Diana
    Chlebowski, Rowan T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 858 - +
  • [28] Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer
    Briest, Susanne
    Wolff, Antonio C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) : 1243 - 1253
  • [29] Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women
    Collin, Lindsay J.
    Cronin-Fenton, Deirdre P.
    Ahern, Thomas P.
    Goodman, Michael
    McCullough, Lauren E.
    Waller, Lance A.
    Kjaersgaard, Anders
    Damkier, Per
    Christiansen, Peer M.
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Sorensen, Henrik Toft
    Lash, Timothy L.
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1421 - 1428
  • [30] Endocrine therapy for advanced breast cancer in premenopausal women
    Jonat, W
    ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS, 2004, : 105 - 114